Since December of 2019, the COVID-19 pandemic, caused by SARS-CoV-2, has affected many across the globe. According to the World Health Organization (WHO) Coronavirus Dashboard, there have been more than 570 million confirmed cases of the coronavirus and 6 million deaths as of August 1 st , 2022. As Chinese scientists released the draft genome of the virus to the public soon after the pandemic started, researchers internationally began to craft vaccines and in vitro diagnostics (IVD) methods ranging from molecular assays (MDx) to antigen tests to control and prevent the virus from spreading further. Even after the COVID-19 pandemic, the diagnostic industry is expected to grow by 2.4% to USD 85.81 billion by 2030. And undoubtedly, IVD and MDx play a huge role in the industry's market cap .